Aakaar Medical Technologies Limited — Updates, 10-11-2025: Press Release

Aakaar's half-year results show revenue at ₹25.3 Cr (-8.6% YoY) due to seasonality and tighter credit. EBITDA fell to ₹0.07 Cr, PAT to -₹0.78 Cr, hit by one-time costs. New Exovea division expects ₹6 Cr first-year revenue. IPO funds will strengthen working capital for a strong H2 rebound.